Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

2964

Figures (1-2)

158

Tables (1-2)

141

Sum=3328

Publishing Process of This Article

Item

Count

Browse

Download

114

Sum=153

Jun 21, 2024 (publication date) through Dec 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jun 21, 2024; 30(23): 2964-2980
Published online Jun 21, 2024. doi: 10.3748/wjg.v30.i23.2964

Table 1 Changes in the gut microbiome in patients with metabolic dysfunction-associated fatty liver disease

Increase	Decrease
Genus/species (phylum)	Genus/species (phylum)
Anaerobacter (Firmicutes)	Akkermansia muciniphila (Verrucomicrobiota)
Clostridium (Firmicutes)	Alistipes (Bacteroidetes)
Desulfovibrio (Thermodesulfobacteriota)	Bifidobacterium (Actinomycetota)
Enterobacter (Proteobacteria)	Faecalibacterium prausnitzii (Firmicutes)
Escherichia (Proteobacteria)	Flavonifractor (Firmicutes)
Fusobacterium (Fusobacteriota)	Lactobacillus (Firmicutes)
Mucispirillum (Deferribacterota)	Odoribacter (Bacteroidetes)
Peptoniphilus (Firmicutes)	Oscillibacter (Firmicutes)
Ruminococcus (Firmicutes)	Prevotella (Bacteroidetes)
Streptococcus (Firmicutes)	Rikenellaceae (Bacteroidetes)

Citation: Rochoń J, Kalinowski P, Szymanek-Majchrzak K, Grąt M. Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2024; 30(23): 2964-2980
URL: https://www.wjgnet.com/1007-9327/full/v30/i23/2964.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i23.2964